Neuroleptic malignant syndrome following COVID-19 vaccination
Am J Emerg Med
.
2021 Nov:49:408-409.
doi: 10.1016/j.ajem.2021.02.011.
Epub 2021 Feb 20.
Authors
Mostafa Alfishawy
1
,
Zouheir Bitar
2
,
Amr Elgazzar
2
,
Mahmoud Elzoueiry
2
Affiliations
1
Infectious Diseases Consultants and Academic Researchers of Egypt (IDCARE), Egypt. Electronic address: malfishawy@kasralainy.edu.eg.
2
Ahmadi Hospital of Kuwait Oil Company, Kuwait City, Kuwait.
PMID:
33642127
PMCID:
PMC8555970
DOI:
10.1016/j.ajem.2021.02.011
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Neuroleptic Malignant Syndrome* / diagnosis
Neuroleptic Malignant Syndrome* / etiology
SARS-CoV-2
Vaccination / adverse effects
Substances
COVID-19 Vaccines